alpha7 Nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-alpha production and lung injury

Autor: Matthijs Kox, Esther Peters, J.G. van der Hoeven, Jan C. Pompe, C.W.E. Hoedemaekers, G.J. Scheffer, Michiel Vaneker, Peter Pickkers, J.A.W.M. van der Laak
Rok vydání: 2011
Předmět:
Agonist
Lipopolysaccharides
Male
alpha7 Nicotinic Acetylcholine Receptor
medicine.drug_class
Pyridines
Ventilator-Induced Lung Injury
Acute Lung Injury
Iron metabolism Pathogenesis and modulation of inflammation [IGMD 7]
Perception and Action Auto-immunity
transplantation and immunotherapy [DCN 1]

Nicotinic Antagonists
Lung injury
Pharmacology
Mecamylamine
Receptors
Nicotinic

Auto-immunity
transplantation and immunotherapy [N4i 4]

Benzylidene Compounds
Mice
GTS-21
Translational research [ONCOL 3]
medicine
Animals
Nicotinic Agonists
business.industry
Tumor Necrosis Factor-alpha
Pneumonia
Respiration
Artificial

Neostigmine
Interleukin-10
Pathogenesis and modulation of inflammation [N4i 1]
Mice
Inbred C57BL

Pulmonary Alveoli
Nicotinic acetylcholine receptor
Anesthesiology and Pain Medicine
Acetylcholinesterase inhibitor
Neutrophil Infiltration
Immunology
Cholinergic
Cholinesterase Inhibitors
business
medicine.drug
Zdroj: British Journal of Anaesthesia, 107, 4, pp. 559-66
British Journal of Anaesthesia, 107, 559-66
ISSN: 0007-0912
DOI: 10.1093/bja/aer202
Popis: Contains fulltext : 98553.pdf (Publisher’s version ) (Open Access) BACKGROUND: Mechanical ventilation (MV) induces an inflammatory response that can lead to lung injury. The vagus nerve can limit the inflammatory response through the cholinergic anti-inflammatory pathway. We evaluated the effects of stimulation of the cholinergic anti-inflammatory pathway with the selective partial alpha7 nicotinic acetylcholine receptor (alpha7nAChR) agonist GTS-21 on inflammation and lung injury induced by MV using clinically relevant ventilator settings. Furthermore, we investigated whether altering endogenous cholinergic signalling, by administration of the non-specific nAChR antagonist mecamylamine and the peripherally acting acetylcholinesterase inhibitor neostigmine, modulates the MV-induced inflammatory response. METHODS: C57BL6 mice were injected i.p. with either the selective alpha7nAChR agonist GTS-21 (8 mg kg(-1)), the acetylcholinesterase inhibitor neostigmine (80 mug kg(-1)), the nAChR antagonist mecamylamine (1 mg kg(-1)), or a placebo; followed by 4 h of MV (8 ml kg(-1), 1.5 cm H(2)O PEEP). RESULTS: MV resulted in release of cytokines in plasma and lungs compared with unventilated mice. Lung and plasma levels of tumour necrosis factor (TNF)-alpha, but not of interleukin-10, were lower in GTS-21-treated animals compared with placebo (P
Databáze: OpenAIRE